Q: Hello team,
In order to diversify the portfolio I am looking for some investments in biotech. Since Google recently declared the project for early cancer diagnostics based on nanotech I trust it could be fast growing area (risks are high of course...I understand). At the same time regardless of Google declarations (which might positively affect stock of nanotech companies) their stock behaves consistently bad. Three companies I took are just the example. So stock behavior varies from catastrophic with NSPH to just not good with BIND. Do you have any ideas - is it company related issue or it is trend which shows that market "doesn't believe"?
In order to diversify the portfolio I am looking for some investments in biotech. Since Google recently declared the project for early cancer diagnostics based on nanotech I trust it could be fast growing area (risks are high of course...I understand). At the same time regardless of Google declarations (which might positively affect stock of nanotech companies) their stock behaves consistently bad. Three companies I took are just the example. So stock behavior varies from catastrophic with NSPH to just not good with BIND. Do you have any ideas - is it company related issue or it is trend which shows that market "doesn't believe"?